Stephen Hahn On Risk-Taking, Moving To ‘Friction,’ And What Industry Can Learn From The FDA

 
• By Nielsen Hobbs

The former US FDA commissioner turned venture CEO believes the biopharmaceutical industry can cure many of society’s ills, but firms need to talk to the agency more.

Stephen Hahn
‘Where’s biotech’ in the fight against opioids, asks Flagship Pioneering CEO-Partner Stephen Hahn. • Source: Flagship Pioneering

More from Agency Leadership

More from Pink Sheet